GGrantIndex
← Leaderboards

University Of Virginia

Charlottesville, VA

Compare ↔
$3,135,363,133
Total funding
2,957
Grants

Funding over time

peak $243.2M · FY2006–25
$250M$187.5M$125M$62.5M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$3,127,551,781 · 2943
AHRQ$3,882,294 · 9
CDC$3,618,017 · 6
FDA$2,424,569 · 1

By mechanism

R01$1,906,856,488 · 1065
U01$171,757,784 · 49
P01$142,799,780 · 133
R21$127,136,147 · 320
T32$123,568,990 · 37
R35$78,311,279 · 43

Investigators at University Of Virginia

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Suna Onengut$3,014,3261 gr2Michael D Lyons$2,910,7711 gr3Sanja Arandjelovic$2,284,3603 gr4Elise C Cope$2,001,3662 gr5Stefanie Redemann$1,673,8251 gr6Bowen Wang$1,625,7881 gr7Araceli Elvira Santiago$1,602,4601 gr8Christopher B Highley$1,493,8961 gr

Emerging Leaders

6–10 yrs in

1Bradley David Gelfand$8,956,1176 gr2Margaret Graham Kemper Parker$8,934,8807 gr3John R Lukens$8,429,3038 gr4Philip Chow$6,332,5053 gr5Chongzhi Zang$5,035,1214 gr6Mazhar Adli$4,993,5463 gr7Sana Syed$4,883,5372 gr8Rebecca R Pompano$4,839,6817 gr

All-Time

Most funded here, all years

1Gary K Owens$42,230,16418 gr2William A Petri$30,798,48213 gr3Karen K Hirschi$22,898,70315 gr4Jie Sun$22,468,24313 gr5Harald W Sontheimer$22,196,47511 gr6Jonathan R Lindner$21,881,5818 gr7Ling Qi$16,888,44813 gr8Adam N. Goldfarb$16,754,74413 gr

Largest grants

Clinical Acceptance of the Artificial Pancreas: the International Diabetes Closed Loop (iDCL) Trial$12,653,694
UC4 · FY2016 · DK
Ketamine Add-On for Established Status Epilepticus Treatment Trial (KESETT)$9,296,510
UG3 · FY2025 · NS
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial$8,079,901
U01 · FY2012 · NS
Cell Migration Consortium$7,398,875
U54 · FY2006 · GM
Type 1 Diabetes Genetics Consortium$7,131,908
U01 · FY2006 · DK
Cell Migration Consortium$6,871,091
U54 · FY2007 · GM
Cell Migration Consortium$6,691,448
U54 · FY2010 · GM
Cell Migration Consortium$6,669,335
U54 · FY2008 · GM
Cell Migration Consortium$6,666,763
U54 · FY2009 · GM
Expression and proteomic characterization of risk loci in type 1 diabetes$6,618,593
DP3 · FY2009 · DK
The role of copy number variants (CNV) in type 1 diabetes$6,430,662
DP3 · FY2009 · DK
Established Status Epilepticus Treatment Trial (ESETT)$6,170,975
U01 · FY2014 · NS
The Stroke Hyperglycemia Insulin Network Effort (SHINE) Trial$4,966,983
U01 · FY2014 · NS
General Clinical Research Center$4,931,377
M01 · FY2010 · RR
General Clinical Research Center$4,787,745
M01 · FY2009 · RR
General Clinical Research Center$4,648,293
M01 · FY2008 · RR
General Clinical Research Center$4,605,007
M01 · FY2007 · RR
General Clinical Research Center$4,604,412
M01 · FY2006 · RR
Type 1 Diabetes Genetics Consortium$4,276,715
U01 · FY2007 · DK
The integrated Translational Health Research Institute of Virginia (iTHRIV): Using Data to Improve Health$4,130,473
UL1 · FY2019 · TR